Trademark Search in Canada

PANBIO

View On IC.GC.CA

REGISTERED

on 1 Feb 2023

Last Applicant/ Owned by

ABBOTT RAPID DIAGNOSTICS INTERNATIONAL SUBSIDIARY UNLIMITED COMPANY

70 Sir John Rogerson's QuayDublin 2

Serial Number

2047957 filed on 21^st Apr 2020

Registration Number

TMA1163384 registered on 1^st Feb 2023

Registration expiry Date

21^st Apr 2030

Correspondent Address

BAKER & MCKENZIE LLP

BROOKFIELD PLACE181 BAY STREET, SUITE 2100P.O. BOX 874TORONTO

ONTARIO

M5J2T3

PANBIO

Trademark usage description

chemical preparations for control in vitro diagnostic testing, screening, confirmation and analysis, namely, diagnostic reagents for medical-scientifi Read More

Classification Information

Class [001]
Chemical preparations for control in vitro diagnostic testing, screening, confirmation and analysis, namely, diagnostic reagents for medical-scientific research use; diagnostic reagents and chemical reagents for laboratory or research purposes, namely, in vitro diagnostic reagents for scientific purposes; chemical reagents used in diagnostic test kits for laboratory or research purposes for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; diagnostic test kits for laboratory or research use comprising biological assays and kits for use in fields of biological and diagnostic testing for scientific and research use; diagnostic preparations for medical-scientific research use; diagnostic test kits comprising reagents and assays, namely, biological assays and kits for use in fields of biological and diagnostic testing for scientific and research use; in vitro diagnostic tests for laboratory or research use, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory and research use, other than for medical or veterinary use; in vitro immunochromatographic tests for laboratory or research use, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use.

Classification kind code

Class [005]
Diagnostic kits comprising medical diagnostic bioreagents for testing blood, bodily fluid, nasal samples, oral samples and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic test kits comprising diagnostic agents, preparations and substances for detecting respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic test strips for testing blood, human serum, plasma, bodily fluid, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes for detecting respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; testing preparations for medical use, namely, diagnostic test reagents for medical purposes; diagnostic tests for medical use, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic tests, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; in vitro medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic test kits for use in the field of infectious disease; in vitro medical diagnostic test strips comprising primarily monoclonal antibodies, buffers, and reagents for use in disease testing; in vitro medical diagnostic reagents; in vitro immunochromatographic tests for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of infections, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue.

Classification kind code

Mark Details

Serial Number

2047957

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 16^th Dec 2021	Search Recorded
Submitted for opposition 20 on 16^th Dec 2021	Examiner's First Report
Submitted for opposition 223 on 16^th Dec 2021	Total Provisional Refusal
Submitted for opposition 48 on 5^th Jul 2021	Agent Changed
Submitted for opposition 256 on 28^th Jun 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 27^th Aug 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 26^th Aug 2020	Created
Submitted for opposition 31 on 26^th Aug 2020	Formalized
Submitted for opposition 30 on 21^st Apr 2020	Filed
Submitted for opposition 228 on 21^st Apr 2020	International Registration